The Agenda

A Brief Reply to Austin Frakt

Austin Frakt of The Incidental Economist writes:

A key difference between the exchanges and the Ryan-Rivlin Medicare plan is how vouchers or subsidies would be set. One would use the market, the other would put its faith in a political process. If you don’t know, can you guess which takes which approach? The answer is not what one might guess based on who supports exchanges and who supports the Ryan-Rivlin plan. With respect to setting subsidy levels, the ACA’s exchanges would be more market-based than Ryan-Rivlin voucherized Medicare.

In the exchanges, subsidies will be tied to plans’ market prices. Subsidy levels in an exchange will be based on the premium of the second cheapest “silver” plan. That’s, essentially, competitive bidding. Plans will compete within an exchange, trying to outbid each other to attract enrollees. Subsidies will be tied to those bids, as just explained, and, crucially, to one of the lowest bids. (A “stronger” bidding arrangement would tie subsidies to the absolute lowest, but one could argue that that would leave low-income individuals and families with too few affordable options.)

So, in an exchange, anyone who wants a more expensive or generous plan would pay the marginal cost. Subsidies are only guaranteed to a certain level, and that level is set by the market. Translation: it’s a very market-based approach, one that builds in protections for consumers (it puts a health care cost-adjusting floor under their out-of-pocket costs) and for taxpayers (subsidies can’t grow any faster than the market dictates).

Now, consider the Ryan-Rivlin plan. As I’ve written before, vouchers in that plan would not be tied to the market. They would not be set by a competitive process. According to my conversation with Rep. Ryan’s staff, they would be controlled by the Secretary of HHS. Translation: it’s an administrative pricing approach. Now, in principle, vouchers are not supposed to rise faster than GDP + 1 percentage point. But, we know from Medicare Advantage (MA) that pledges to keep private plan subsidies to a certain level are hard for politicians to keep. MA subsidies grew to about 14% above FFS Medicare costs. The ACA is supposed to pull them back, but, predictably, there has already been some monkeying with the formula.

In Austin’s view, this difference is very important because of how it shapes the political economy of the health system:

Administrative pricing has weak protections for consumers and puts taxpayers at political risk for costs. As we’ve seen in the Medicare Advantage program, that political risk is a real one. Costs have not been controlled in that program.

Competitive pricing provides greater protection for consumers from health care cost risk and puts taxpayers at market risk. It depends on price competition to control health care costs. In so doing, it ties taxpayers, through the government, to the performance of the market with respect to health care cost control. In other words, it aligns the government with the market in terms of incentives to keep costs down.

My take is that while Austin might be overly optimistic about the PPACA exchanges, he is right to suggest that using competitive bids to set premium support makes sense. Don’t be surprised if you see a proposal to incorporate competitive bidding into the Rivlin-Ryan framework in the near future. 

Reihan Salam is president of the Manhattan Institute and a contributing editor of National Review.
Exit mobile version